Cargando…
Leukotrienes as Modifiers of Preclinical Atherosclerosis?
Preclinical atherosclerosis represents a crucial period associated with several pathophysiological reactions in the vascular wall. Failure to diagnose preclinical atherosclerosis at this stage misses a major opportunity to prevent the long-term consequences of this disease. Surrogate biological and...
Autores principales: | Riccioni, Graziano, Bäck, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific World Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354776/ https://www.ncbi.nlm.nih.gov/pubmed/22645425 http://dx.doi.org/10.1100/2012/490968 |
Ejemplares similares
-
Leukotrienes in Atherosclerosis: New Target Insights and Future Therapy Perspectives
por: Riccioni, Graziano, et al.
Publicado: (2009) -
Role of Leukotrienes and Leukotriene Modifiers in Asthma
por: Montuschi, Paolo
Publicado: (2010) -
Leukotriene Receptors: Crucial Components in Vascular Inflammation
por: Bäck, Magnus
Publicado: (2007) -
Atherosclerosis: from biology to pharmacological treatment
por: Riccioni, Graziano, et al.
Publicado: (2012) -
Leukotriene Production Is Increased in Abdominal Obesity
por: Bäck, Magnus, et al.
Publicado: (2014)